Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
Yu, W., Smil, D., Li, F., Tempel, W., Fedorov, O., Nguyen, K.T., Bolshan, Y., Al-Awar, R., Knapp, S., Arrowsmith, C.H., Vedadi, M., Brown, P.J., Schapira, M.(2013) Bioorg Med Chem 21: 1787-1794
- PubMed: 23433670 
- DOI: 10.1016/j.bmc.2013.01.049
- Primary Citation of Related Structures:  
3SX0 - PubMed Abstract: 
Chemical inhibition of proteins involved in chromatin-mediated signaling is an emerging strategy to control chromatin compaction with the aim to reprogram expression networks to alter disease states. Protein methyltransferases constitute one of the protein families that participate in epigenetic control of gene expression, and represent a novel therapeutic target class ...